|
Re: New Trial: Continuation Protocol for ZEN003694 in mCRPC Patients
|
3
|
Zenith Epigenetics
|
Oct 30, 2019 06:15PM
|
|
Re: Comments on the AGM
|
5
|
Resverlogix Corp.
|
Nov 09, 2019 09:36AM
|
|
AHA late breaking abstract
|
8
|
Resverlogix Corp.
|
Nov 10, 2019 11:00AM
|
|
FDA Technology Modernization Action Plan courtesy of rndtbl on IV
|
6
|
Resverlogix Corp.
|
Nov 11, 2019 10:36AM
|
|
FDA confirmation of filing June 2018
|
5
|
Resverlogix Corp.
|
Nov 13, 2019 02:18PM
|
|
Re: 3 straight days of declining volume....
|
3
|
Resverlogix Corp.
|
Nov 15, 2019 09:37AM
|
|
Re: 3 straight days of declining volume....OFF TOPIC
|
3
|
Resverlogix Corp.
|
Nov 15, 2019 10:53AM
|
|
Re: AGM comment - Monday more important than today?
|
7
|
Resverlogix Corp.
|
Nov 16, 2019 02:22PM
|
|
Re: “We will see how close we got”.....
|
9
|
Resverlogix Corp.
|
Nov 17, 2019 10:06AM
|
|
Re: This is a Drug for people at the end of their life...CHF and advanced kidney disease...so is Dementia next?
|
7
|
Resverlogix Corp.
|
Nov 18, 2019 09:49AM
|
|
Re: This is a Drug for people at the end of their life...CHF and advanced kidney disease...so is Dementia next?
|
4
|
Resverlogix Corp.
|
Nov 18, 2019 09:53AM
|
|
Re: Exceptionally good news
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 11:37AM
|
|
Re: Age, MoCA and CKD
|
5
|
Resverlogix Corp.
|
Nov 19, 2019 02:59PM
|
|
Re: Zenith AGM Corporation Update Slides and Webcast
|
3
|
Zenith Epigenetics
|
Nov 20, 2019 11:14AM
|
|
Re: Zenith AGM Corporation Update Slides and Webcast
|
5
|
Zenith Epigenetics
|
Nov 20, 2019 01:15PM
|
|
Re: Positives vs. negatives
|
6
|
Resverlogix Corp.
|
Nov 20, 2019 03:16PM
|
|
Re: Anyone find it odd?
|
3
|
Zenith Epigenetics
|
Nov 21, 2019 07:30AM
|
|
Re: Trial
|
4
|
Zenith Epigenetics
|
Nov 21, 2019 01:09PM
|
|
Re: Trial
|
6
|
Zenith Epigenetics
|
Nov 21, 2019 01:49PM
|
|
New article on Dementia in the US
|
1
|
Resverlogix Corp.
|
Nov 23, 2019 10:11AM
|
